Detalhe da pesquisa
1.
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Blood
; 139(16): 2499-2511, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995350
2.
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Br J Haematol
; 201(4): 673-681, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799516
3.
Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning.
Ann Hematol
; 102(8): 2225-2231, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380715
4.
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.
J Med Internet Res
; 25: e38619, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790852
5.
R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment: A eight-year trajectory study.
Eur J Haematol
; 105(2): 223-230, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302426
6.
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.
Am J Hematol
; 99(2): E46-E50, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037530
7.
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.
Ann Hematol
; 97(12): 2391-2401, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091022
8.
Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(1): 140-146, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27751934
9.
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Biol Blood Marrow Transplant
; 20(9): 1349-55, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24838178
10.
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Am J Hematol
; 89(11): 1024-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052698
11.
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.
Haematologica
; 103(8): e360-e363, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545337
12.
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).
Eur J Haematol
; 90(3): 177-86, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23301689
13.
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
J Clin Oncol
; 41(19): 3523-3533, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071836
14.
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.
Blood Adv
; 6(1): 207-211, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844264
15.
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Biol Blood Marrow Transplant
; 17(11): 1698-703, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21601642
16.
Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis.
J Allergy Clin Immunol
; 135(3): 818-20.e4, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25420683
17.
Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement.
Cancers (Basel)
; 13(12)2021 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204600
18.
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO).
Hemasphere
; 4(5): e473, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33062946
19.
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Oncotarget
; 7(51): 85573-85583, 2016 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458168
20.
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.
Transplantation
; 99(8): 1672-80, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25769079